Olivier Vidalin is currently the Head of Group Biotechnology R&D at SEQENS and also serves as the Scientific Manager at Proteus by Seqens. Previously, Olivier worked as a Senior Program Manager at Sensorion and held roles as a Senior Scientist and Principal Scientist at GlaxoSmithKline. Olivier has extensive experience in scientific research and development, including a significant tenure at TOTAL Refining & Chemicals. Olivier completed a PhD at INSERM U271 and was a Marie Curie PostDoc.
This person is not in any teams
This person is not in any offices